CAN/CSA-Z10524-3-12:2017 – Pressure Regulators Integrated with Cylinder Valves for Medical Gases

National Standard of Canada for VIPR Devices: Design, Performance, and Compliance Requirements

1. Scope and Application

CAN/CSA-Z10524-3-12:2017 is the National Standard of Canada for pressure regulators integrated with cylinder valves (VIPR – Valve Integrated Pressure Regulator) intended for use with medical gases. This standard is the Canadian adoption of ISO 10524-3:2005 with national deviations to align with Canadian regulatory requirements and clinical practice. It applies to VIPR devices that are attached to or form a part of the cylinder valve assembly and deliver a regulated outlet pressure for medical gas administration.

The standard covers regulators designed for gases such as oxygen, nitrous oxide, medical air, carbon dioxide, and specified mixtures. It does not apply to pressure regulators for welding, industrial gases, or diving applications, nor to stand-alone pressure regulators covered by other parts of the CSA Z10524 series. The standard addresses all stages from design and material selection through production testing and marking, ensuring patient and operator safety in healthcare environments.

2. Key Technical Requirements

CAN/CSA-Z10524-3-12:2017 establishes comprehensive requirements for VIPR devices. These are divided into design, performance, and safety categories.

2.1 Design and Material Requirements

Materials in contact with medical gases must comply with biocompatibility and corrosion resistance criteria. The standard references material specifications such as ASTM F139 for stainless steel and ISO 5832 for implantable materials where applicable. All wetted parts must be compatible with the intended gas and cleaning agents, and must not promote microbial growth. The VIPR must pass a visual inspection for cleanliness per ISO 10524-1 (or CSA Z10524-1) and any national deviations regarding particulate limits.

Outlet connections must conform to CSA Z10524-1 or ISO 407 for pin-index systems (for gases other than oxygen) or ISO 13341 for permanent connections. Oxygen-specific connections must be non-interchangeable to prevent misconnection with other gas supplies.

2.2 Performance Requirements

The standard defines tests for:

  • Inlet pressure rating:The VIPR must withstand the maximum cylinder pressure (typically 200 bar at 15°C for oxygen) plus safety factors.
  • Outlet pressure regulation:The set pressure must stay within ±20% of the nominal value over the range from full cylinder pressure to 10% of the full pressure, with a maximum flow rate of 60 L/min for oxygen.
  • Relief valve operation:If the VIPR incorporates an integral pressure relief device, it must open at a pressure not exceeding the hydrostatic test pressure of the cylinder valve and close at a pressure above the regulated outlet maximum.
  • Leakage:External leakage shall not exceed 0.5 mL/min at any test condition. Internal leakage (across the regulating seat) shall not exceed 1.0 mL/min when the device is in the closed position.
  • Durability cycle test:The device must survive 10,000 cycles of opening/closing from full cylinder pressure to empty and back, after which performance must still meet all requirements.

3. Implementation and Testing Considerations

CAN/CSA-Z10524-3-12:2017 requires that the VIPR manufacturer conduct a full type test on the design, followed by routine production testing on each unit. The following table summarizes the key type tests defined in the standard.

Test Condition / Parameter Acceptance Criteria
Hydrostatic strength (valve body) 1.5 × maximum cylinder pressure for 2 min No permanent deformation, no leakage
Regulation accuracy Flow from 0 to 60 L/min (oxygen), 0 to 30 L/min (nitrous oxide) Outlet pressure within ±20% of nominal, with minimum flow
Internal leakage (closed) Measure at regulated outlet with inlet at full pressure Leakage ≤ 1.0 mL/min
External leakage All seals, joints, and valve stem Leakage ≤ 0.5 mL/min
Durability cycling 10,000 cycles at rated temperature range All performance criteria still met
Icing / low temperature Deactivation test at -40 °C or -20 °C depending on service No obstruction from ice; device must function normally
Tip: When implementing design validation, test the VIPR with the actual cylinder valve assembly intended for production. Small changes in valve geometry can affect the pressure regulation curve.

Manufacturers must also ensure that the VIPR device does not inadvertently restrict cylinder filling operations. The standard prohibits any internal component that could block the filling port when the cylinder valve is open. In addition, clear marking must be present on the device showing the gas symbol, nominal outlet pressure, and the temperature range for use.

Warning: Attention must be paid to the Canadian deviation regarding the maximum working pressure for oxygen. While ISO 10524-3 allows up to 300 bar, CAN/CSA-Z10524-3-12 limits the inlet pressure to 200 bar for oxygen cylinders transported in Canada due to transport regulations (TDG). The VIPR must be clearly marked accordingly.

4. Compliance and Regulatory Landscape

CAN/CSA-Z10524-3-12:2017 is referenced by several Canadian regulatory frameworks. The Medical Devices Regulations (SOR/2000-117) under the Food and Drugs Act require that medical gas pressure regulators, including VIPR devices, be licensed as Class II medical devices. Compliance with this standard is generally accepted as providing a presumption of conformity to the safety and performance requirements for device licensing in Canada.

Additionally, these devices fall under the scope of CSA B51 (Boiler, Pressure Vessel, and Pressure Piping Code) for the cylinder valve interface and CSA Z10524-1 for general pressure regulator requirements. The National Standard is harmonized with ISO 10524-3 but includes modifications to reflect Canadian gas supply practices, marking language (bilingual English/French), and specific testing conditions for cold climate operation.

Compliance Strategy: To streamline certification, manufacturers should first obtain ISO 10524-3:2005 type approval from an accredited testing laboratory, then address the Canadian deviations (marking, cold test, connection standards, and documentation language). This approach reduces duplicate testing costs.
Important: As of 2025, the CSA Z10524-3 series is under revision to align with ISO 10524-3:2018. Manufacturers should monitor the coming amendment to ensure that devices designed after 2025 will meet future edition requirements, especially regarding changes in flow rate test conditions and leakage limits.

In summary, CAN/CSA-Z10524-3-12:2017 is an essential standard for the design, testing, and market entry of VIPR devices in Canada. Understanding its scope, technical demands, and regulatory links is crucial for engineers, quality assurance professionals, and regulatory affairs teams in the medical gas equipment industry.


Frequently Asked Questions (FAQs)

Q: Does CAN/CSA-Z10524-3-12:2017 apply to VIPR devices used with gas mixtures (e.g., entonox or oxygen/nitrous oxide blends)?
A: Yes. The standard covers VIPRs for medical gases and specified mixtures. However, additional validation tests must be performed using the actual gas mixture to confirm that regulation accuracy and materials compatibility are maintained. The standard also notes that mixtures with oxidizing properties may affect ignition risk, so material selection must consider this.
Q: What are the main differences between the Canadian standard and the ISO 10524-3:2005 or 2018 versions?
A: Key differences include: (1) inlet pressure limited to 200 bar for oxygen; (2) requirement for bilingual (English/French) marking and documentation; (3) low temperature test at -40°C instead of -20°C for equipment intended for Canadian winter use; (4) specific reference to CSA B51 for cylinder valve interface strength; and (5) adoption of CSA Z10524-1 connections rather than ISO 407 for certain outlet connectors.
Q: How is the standard referenced in Health Canada’s medical device licensing process?
A: When applying for a medical device licence for a VIPR under Class II (SOR/2000-117), manufacturers must submit evidence of compliance with recognized standards. CAN/CSA-Z10524-3-12:2017 is listed as a recognized standard in Health Canada’s Standards Recognition list. A conformity assessment report from an accredited testing body (e.g., CSA Group, UL, SGS) demonstrating full compliance with the standard will satisfy the safety and effectiveness requirements for licensing.
Q: Can a device that meets ISO 10524-3:2018 be placed on the Canadian market without further testing?
A: Not automatically. The ISO version is not directly recognized in Canada. The device must demonstrate compliance with the Canadian standard (CAN/CSA-Z10524-3-12). However, if the ISO testing already covers the same or more severe conditions, manufacturers may request a gap analysis. Additional testing for Canadian-specific requirements (e.g., cold test, language marking) will still be needed. Some testing laboratories offer combined testing to both standards to minimize duplication.

This article is for informational purposes and does not substitute for the full text of the standard. Readers should refer to the official CAN/CSA-Z10524-3-12:2017 document for authoritative requirements.

Last reviewed: 2026

📥 Standard Documents Download

🔒
Please wait 10 seconds, the download links will appear after the ad loads

Leave a Reply

Your email address will not be published. Required fields are marked *